| # | Drug | Count |
|---|---|---|
| 0 | APIXABAN | 254 |
| 1 | ASPIRIN | 245 |
| 2 | RIVAROXABAN | 231 |
| 3 | ASPIRIN 325 MG | 225 |
| 4 | ASPIRIN 81 MG | 225 |
| 5 | FUROSEMIDE | 203 |
| 6 | WARFARIN | 161 |
| 7 | CLOPIDOGREL | 158 |
| 8 | IBRUTINIB | 119 |
| 9 | PREDNISOLONE | 111 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CONCIZUMAB | 2 | 0.0444 |
| 1 | ALVIMOPAN | 1 | 0.0217 |
| 2 | 5-HYDROXYTRYPTOPHAN | 1 | 0.0189 |
| 3 | COAGULATION FACTOR IX RECOMBINANT HUMAN | 13 | 0.0116 |
| 4 | ZANUBRUTINIB | 45 | 0.0099 |
| 5 | DIMETICONE | 2 | 0.0071 |
| 6 | AMIVANTAMAB AND HYALURONIDASE-LPUJ (HUMAN RECOMBINANT) | 2 | 0.0065 |
| 7 | ANTIHEMOPHILIC FACTOR (RECOMBINANT) | 51 | 0.0062 |
| 8 | ANTI-INHIBITOR COAGULANT COMPLEX | 6 | 0.0054 |
| 9 | AURANOFIN | 1 | 0.0049 |
| # | Drug class | Count |
|---|---|---|
| 0 | Factor Xa Inhibitor [EPC] | 480 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 358 |
| 2 | Corticosteroid [EPC] | 278 |
| 3 | Kinase Inhibitor [EPC] | 265 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 255 |
| 5 | Loop Diuretic [EPC] | 220 |
| 6 | Proton Pump Inhibitor [EPC] | 183 |
| 7 | Dihydropyridine Calcium Channel Blocker [EPC] | 108 |
| 8 | Benzodiazepine [EPC] | 104 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 102 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tissue Factor Pathway Inhibitor Antagonist [EPC] | 2 | 0.0444 |
| 1 | Complement C5 Inhibitor [EPC] | 1 | 0.0083 |
| 2 | Interleukin-5 Antagonist [EPC] | 4 | 0.0058 |
| 3 | Endoglycosidase [EPC] | 6 | 0.0032 |
| 4 | Guanylate Cyclase-C Agonist [EPC] | 5 | 0.0024 |
| 5 | Phosphodiesterase 3 Inhibitor [EPC] | 15 | 0.0024 |
| 6 | Benzodiazepine Antagonist [EPC] | 2 | 0.0023 |
| 7 | Provitamin D2 Compound [EPC] | 65 | 0.0022 |
| 8 | Factor Xa Inhibitor [EPC] | 480 | 0.0017 |
| 9 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 3 | 0.0013 |